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Enpp1 is an anti-aging factor that 
regulates Klotho under phosphate 
overload conditions
Ryuichi Watanabe1, Nobuyuki Fujita1, Yuiko Sato1,2, Tami Kobayashi1,3, Mayu Morita4, 
Takatsugu Oike1, Kana Miyamoto1, Makoto Kuro-o5, Toshimi Michigami6, Seiji Fukumoto  7, 
Takashi Tsuji1, Yoshiaki Toyama1, Masaya Nakamura1, Morio Matsumoto1 & Takeshi Miyamoto1,2
Control of phosphate metabolism is crucial to regulate aging in mammals. Klotho is a well-known 
anti-aging factor that regulates phosphate metabolism: mice mutant or deficient in Klotho exhibit 
phenotypes resembling human aging. Here we show that ectonucleotide pyrophosphatase/
phosphodiesterase 1 (Enpp1) is required for Klotho expression under phosphate overload conditions. 
Loss-of-function Enpp1ttw/ttw mice under phosphate overload conditions exhibited phenotypes 
resembling human aging and Klotho mutants, such as short life span, arteriosclerosis and osteoporosis, 
with elevated serum 1,25(OH)2D3 levels. Enpp1ttw/ttw mice also exhibited significantly reduced renal 
Klotho expression under phosphate overload conditions, and aging phenotypes in these mice were 
rescued by Klotho overexpression, a low vitamin D diet or vitamin D receptor knockout. These findings 
indicate that Enpp1 plays a crucial role in regulating aging via Klotho expression under phosphate 
overload conditions.
A fundamental question in human biology is what mechanisms underlie aging. Aging is reportedly defined as 
age-related deterioration of physiological functions necessary for survival and fertility1. Several phenotypes asso-
ciated with aging have been identified, such as short life span, osteoporosis, arteriosclerosis, cancer and cataract 
development. To date, various mouse models showing premature aging syndromes have been established and 
characterized, such as Klotho (kl/kl)-2, SAM-3, ATM-4, p53-5, FoxOs-6, telomerase7-, and Fetuin A-deficient8 
mice; however, none exhibits the full range of aging phenotypes.
Among models of aging, the kl/kl mouse is best known for showing premature aging phenotypes including 
short life span, osteoporosis and arteriosclerosis2. Klotho is a transmembrane protein that gives rise to a solu-
ble form when cleaved at the cell surface. The transmembrane Klotho (αKlotho) forms a heterocomplex with 
fibroblast growth factor receptors (FGFRs) required for high affinity FGF23 binding and signaling9–11. FGF23 
gain-of-function mutations reportedly underlie autosomal dominant hypophosphatemic rickets (ADHR)12, 13, 
evidence that FGF23 regulates phosphate metabolism. FGF23-deficient mice reportedly exhibit aging-related phe-
notypes similar to kl/kl mice14, suggesting that FGF23 and Klotho co-operate in regulating phosphate metabolism. 
Klotho and FGF23 are reported required to regulate circulating 1,25(OH)2D3 levels by suppressing expression of 
cyp27b1 in the kidney15, 16. Indeed, premature aging phenotypes seen in either kl/kl or FGF23-deficient mice 
are completely rescued by ablation of the Vitamin D receptor (VDR)17–19. Loss-of-function mutations in either 
KLOTHO or FGF23 reportedly cause tumoral calcinosis in humans, a disease characterized by ectopic, vascular 
calcifications20, 21. FGF23 is mainly produced in bone5, and FGF23 secretion in bone is stimulated by 1,25(OH)2D3 
and by increased extracellular phosphate, an activity regulated in a feedback loop between bone and kidney22, 23. 
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In contrast, Klotho expression is downregulated by phosphate24 and reportedly regulated epigenetically25. 
However, mechanisms underlying Klotho regulation are unclear, and there are as yet no animal models resem-
bling kl/kl mice that have been established by deleting factors regulating Klotho.
Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Enpp1) is a single-pass transmembrane protein and 
major generator of extracellular pyrophosphate (PPi), which inhibits hydroxyapatite crystal deposition26. ENPP1 
mutations cause autosomal recessive hypophosphatemic rickets (ARHR) or Generalized Arterial Calcification 
of Infancy (GACI) in humans27–30. ARHR caused either by ENPP1 mutation or mutations in PHEX or DMP1 
genes is marked by high circulating FGF23 levels31, 32. In contrast, GACI is a rare autosomal-recessive disorder 
characterized by calcification of diffuse vascular and periarticular soft-tissues, and few GACI patients survive 
the neonatal period33. ENPP1 mutations are also seen in patients with ossification of the posterior longitudinal 
ligament (OPLL), a disease characterized by ectopic ossification in a spinal ligament, although mechanisms are 
unknown34–36. The Enpp1 mutants Enpp1ttw/ttw or Enpp1asj/asj reportedly exhibit OPLL- or GACI-like, respectively, 
phenotypes37, 38.
Here, we show that Enpp1 acts as an anti-aging factor under phosphate overload by regulating Klotho expres-
sion. Enpp1ttw/ttw or genetically engineered Enpp1-deleted mice (Enpp1Δ/Δ) exhibited premature aging pheno-
types, such as short life span and arteriosclerosis, phenotypes resembling kl/kl mice and human aging, under 
phosphate overload. Klotho expression in kidney was significantly downregulated in Enpp1ttw/ttw mice by phos-
phate overload, and premature aging phenotypes seen in Enpp1ttw/ttw mice under overload conditions were com-
pletely rescued by VDR ablation. Thus, Enpp1-Klotho-VDR signals are required to prevent premature aging 
phenotypes, particularly under phosphate overload conditions.
Results
Enpp1 mutation causes premature aging phenotypes under phosphate overload. Enpp1 muta-
tions cause several human diseases, among them AHRH, GACI or OPLL12–15. Enpp1ttw/ttw mice are Enpp1 muta-
tion mouse models that exhibit OPLL-like phenotypes38. We confirmed that at 8 weeks of age Enpp1ttw/ttw mice 
show significantly lower serum phosphate (Pi) levels relative to controls, an outcome also seen in ARHR patients 
(Fig. 1a). Although not statistically significant, serum calcium levels were elevated in both WT or Enpp1ttw/ttw mice 
by a high phosphate diet (HPD) (Fig. 1a). However, feeding 8-week old Enpp1ttw/ttw mice a HPD did not elevate 
serum phosphate levels in as it did in wild-type (WT) mice (Fig. 1a). Ectopic calcification in the ear was previ-
ously demonstrated to be accelerated by feeding Enpp1ttw/ttw mice a HPD39. We found that HPD worsened OPLL 
phenotypes, as shown by elevated ectopic calcification in the posterior longitudinal ligament (PLL) of Enpp1ttw/ttw 
mice (Fig. 1b). Moreover, after phosphate overload, Enpp1ttw/ttw mice showed body weight loss (Fig. 1c), became 
inactive and marantic, and died within three weeks (Fig. 1d). Enpp1ttw/ttw mice fed a phosphate diet also exhibited 
ectopic calcification in aorta and kidney (Fig. 1e), atrophic skin (Fig. 1f) and osteoporotic reduced bone mass 
(Fig. 1g), all premature aging phenotypes seen in kl/kl mice and aging humans2.
Enpp1ttw/ttw mice showed calcification in kidney and aorta at cellular levels (Supplementary Fig. 1a). Expression 
of runt-related transcription factor 2 (Runx2), a factor essential for osteoblastogenesis40, was significantly upreg-
ulated in aorta of Enpp1ttw/ttw mice fed a HPD rather than a normal diet (Supplementary Fig. 1b), suggesting that 
ectopic ossification is likely due to trans-differentiation of cells into an osteoblastic lineage. Although, no differ-
ences were detected in senescence-associated beta-galactosidase (SA β-gal) staining, expression of p16, another 
aging-related factor, increased in kidney of Enpp1ttw/ttw mice fed a HPD relative to that of Enpp1ttw/ttw mice fed a 
ND or wild-type (WT) mice fed either diet (Supplementary Fig. 2).
We also found that serum levels of receptor activator of nuclear factor kappa B ligand (RANKL), a cytokine 
essential for osteoclastogenesis41, increased in Enpp1ttw/ttw mice fed a HPD compared with Enpp1ttw/ttw mice fed a 
ND or WT mice fed either diet (Supplementary Fig. 3a), but serum osteoprotegerin (OPG), a natural agonist of 
RANKL42, also increased (Supplementary Fig. 3b), and as a result, the serum RANKL/OPG ratio was comparable 
in Enpp1ttw/ttw mice fed a HPD relative to Enpp1ttw/ttw mice fed a ND or WT mice fed either diet (Supplementary 
Fig. 3c). However, osteoclast bone resorbing activity, as measured by serum CTx levels, was significantly elevated 
in Enpp1ttw/ttw mice fed a HPD, suggesting that decreased bone mineral density is due at least in part to elevated 
osteoclast bone-resorption (Supplementary Fig. 3d).
Although statistically not significant, serum creatinine and blood urinary nitrogen (BUN) levels were elevated 
in Enpp1ttw/ttw mice fed a HPD relative to Enpp1ttw/ttw mice fed a ND or WT mice fed either diet, and urine volume 
was significantly decreased in Enpp1ttw/ttw mice fed a HPD compared to WT mice fed a HPD diet (Supplementary 
Fig. 4a and b), suggesting that Enpp1ttw/ttw mice fed a HPD undergo renal dysfunction. Urinary calcium was ele-
vated by HPD in WT mice, a phenotype not seen in Enpp1ttw/ttw mice fed a HPD (Supplementary Fig. 4c). In con-
trast, urinary phosphate and creatinine levels were elevated and downregulated, respectively, in both Enpp1ttw/ttw  
and WT mice by HPD (Supplementary Fig. 4c).
In contrast, Hyp mice, a different model of hypophosphatemic rickets caused by mutation in the Phex gene, 
did not exhibit premature aging or OPLL phenotypes even when fed a HPD (Fig. 2). Eight-week-old Hyp mice 
were fed a HPD for two weeks, but since mice exhibited no obvious phenotypes, feeding of the HPD was extended 
six weeks longer (Fig. 2). HPD effectively elevated serum phosphate levels in these Hyp mice (data not shown), 
as previously described43, an effect not seen in Enpp1ttw/ttw mice fed the same diet for two weeks (Fig. 1a). Unlike 
Enpp1ttw/ttw mice, which exhibited visible aging phenotypes after two weeks of phosphate overload, Hyp mice were 
normal in appearance (Fig. 2a), nor did they exhibit lethality after eight weeks of phosphate overload (Fig. 2b). 
Soft X-ray images showed that Enpp1ttw/ttw showed kyphosis by two weeks of HPD feeding, but Hyp mice did not 
become kyphotic even after eight weeks of phosphate overload (Fig. 2c). Hyp mice at eight weeks of phosphate 
overload did not show OPLL, renal or aortic calcification (Fig. 2d and e). Enpp1 expression in kidney was sig-
nificantly higher in Hyp than in WT mice and was significantly upregulated by HPD in mice of either genotype 
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Figure 1. A high phosphate diet promotes premature aging phenotypes in Enpp1ttw/ttw mice. Eight-week-old 
wild-type and Enpp1ttw/ttw mice were fed a normal (ND) or high phosphate (HPD) diet for two (a–c, e–g) 
to twenty weeks (d). The following parameters were then analyzed: serum phosphate and calcium levels 
(a); ectopic calcification at the posterior longitudinal ligaments and intervertebral discs micro-computed 
tomography (b); body weight changes (c); survival rate (each group; n = 10) (d); ectopic calcification in kidney 
and aorta by von Kossa staining (e); skin atrophy by HE staining (upper, f); gross appearance (lower, f); and 
bone mineral density (BMD) of femurs equally divided longitudinally by DEXA (g) after feeding a HPD. Data 
represent mean indicated parameters ± S.D. (*p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant; n = 5 or 6; 
c and g, Enpp1ttw/ttw mice fed a ND vs HPD). Arrowheads in (b) represent OPLL formation. Bar = 100 μm (e). 
Representative data of at least two independent experiments are shown.
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Figure 2. Hyp mice fed a high phosphate diet do not exhibit aging phenotypes. Eight-week-old wild-type or 
Hyp mice were fed with normal (ND) or high phosphate (HPD) diet for eight weeks. Mice were then analyzed 
for: gross appearance (a); survival rate (each group; n = 6) (b); soft X-ray images of total spine (c); ectopic 
calcification around vertebral bones by micro-computed tomography (d); ectopic calcification in kidney and 
aorta by von Kossa staining. Bar = 100 μm (e); and Enpp1 expression in femoral bones by realtime PCR (f). Data 
in (f) represents mean Enpp1 expression relatibe to β-actin ± S.D. (*p < 0.05; ***p < 0.001; ns, not significant; 
n = 6). Representative data of at least two independent experiments are shown.
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(Fig. 2f). These results suggest that in mice, premature aging phenotypes associated with phosphate overload are 
not common to all cases of hypophosphatemic rickets mice but rather they require mutation in Enpp1.
Enpp1ttw/ttw mice under phosphate overload show reduced Klotho expression. Aging phenotypes 
seen in Enpp1ttw/ttw mice fed a HPD, such as short lifespan and ectopic calcifications, resemble those seen in kl/kl 
mice, and kl/kl mice reportedly exhibit abnormal correlation between serum FGF23 and 1,25(OH)2D3 levels44. 
Moreover, both factors are known to regulate serum phosphate levels. Thus, we fed eight-week-old wild-type 
or mutant mice a normal or HPD for two weeks, since Enpp1ttw/ttw mice fed a HPD died within three weeks of 
feeding (Fig. 1), and then analyzed both for serum FGF23 and active vitamin D3, 1,25(OH)2D3, levels. Both were 
upregulated significantly in Enpp1ttw/ttw compared with control mice under phosphate overload (Fig. 3a and b). 
1,25(OH)2D3 is derived from 25(OH)D3 due to hydroxylation by the enzyme cyp27b145. In accordance, serum 
25(OH)D3 levels were significantly lower in Enpp1ttw/ttw mice fed a HPD compared with those fed a normal diet 
or wild-type mice fed either diet (Fig. 3b). Serum PTH levels were also significantly elevated in WT or Enpp1ttw/ttw  
mice fed a HDP (Fig. 3c). FGF23 is known to down-regulate 1,25(OH)2D314; thus it is unusual that FGF23 and 
1,25(OH)2D3 levels would be concomitantly elevated, as seen in Enpp1ttw/ttw mice. However, Klotho mutant mice 
reportedly show elevated levels of both FGF23 and 1,25(OH)2D3 in sera2, suggesting that Klotho expression is sup-
pressed in Enpp1ttw/ttw mice under phosphate overload. Furthermore, since aging phenotypes in Enpp1ttw/ttw mice 
under phosphate overload phenocopy kl/kl mice, we next analyzed Klotho expression in Enpp1ttw/ttw mouse kidney 
(Fig. 3d and Supplementary Fig. 5). As expected, renal Klotho mRNA and protein expression were significantly 
lower in Enpp1ttw/ttw than in wild-type mice under phosphate overload conditions (Fig. 3d and Supplementary 
Fig. 5). Klotho reportedly antagonizes expression of the sodium-phosphate co-transporter NaPi-IIa, also called 
solute carrier family 34 (sodium phosphate), member 1 (Slc34a1)46. Indeed, we observed elevated NaPi-IIa 
expression inversely correlated with Klotho expression in Enpp1ttw/ttw mice fed a HPD (Fig. 3d and Supplementary 
Fig. 5). Furthermore, Klotho is reportedly required to inhibit cyp27b147. We found that cyp27b1 expression in kid-
ney was significantly upregulated in Enpp1ttw/ttw mice fed a HPD compared with those fed a normal diet (Fig. 3d), 
potentially due to inhibited Klotho expression.
To confirm that aging phenotypes seen in Enpp1ttw/ttw mice following phosphate overload are due to reduced 
Klotho expression, we crossed the Enpp1ttw/ttw mice with Klotho-overexpressing transgenic (Klotho Tg) mice, an 
approach that reportedly rescues aging phenotypes in kl/kl mice2 (Supplementary Fig. 6). In resultant mice fed a 
HPD, shortened life span was rescued in part (Supplementary Fig. 6a), while ectopic calcification in aorta was sig-
nificantly rescued compared to similarly fed Enpp1ttw/ttw mice (Supplementary Fig. 6b). These results support the 
idea that under phosphate overload, decreased Klotho expression due to Enpp1 mutation promotes development 
of aging phenotypes in Enpp1ttw/ttw mice. We also observed OPLL-like peri-vertebral bone phenotypes in kl/kl 
mice (Supplementary Fig. 7), as is seen in Enpp1ttw/ttw mice (Fig. 1b), suggesting that the Enpp1-Klotho axis is 
required to prevent ectopic calcification and aging phenotypes under phosphate overload conditions.
Elevated vitamin D levels promote aging phenotypes in Enpp1ttw/ttw mice under phosphate 
overload. Serum 1,25(OH)2D3 levels were significantly elevated in Enpp1ttw/ttw mice fed a HPD (Fig. 1a), and 
high 1,25(OH)2D3 levels reportedly cause premature aging phenotypes in kl/kl mice14. Thus, we asked whether 
elevated serum 1,25(OH)2D3 levels promote aging phenotypes in Enpp1ttw/ttw mice under phosphate overload 
conditions (Fig. 4). To do so, we fed Enpp1ttw/ttw mice a high phosphate/reduced vitamin D diet (HPLD) starting 
at 8 weeks of age (Fig. 4). Compared with animals fed a HPD only, serum phosphate and calcium levels were 
down-regulated in Enpp1ttw/ttw mice fed a high phosphate/low vitamin D (HPLD) diet (Fig. 4a). Urinary calcium 
and creatinine levels were elevated in both WT and Enpp1ttw/ttw mice fed a HPLD compared with those fed a HPD 
(Supplementary Fig. 8). Urinary phosphate levels were comparable in WT and Enpp1ttw/ttw mice fed a HPLD 
(Supplementary Fig. 8). Serum 1,25(OH)2D3 and FGF23 levels were down-regulated in both WT or Enpp1ttw/ttw 
mice fed a HPLD (Fig. 4b). Moreover, serum PTH levels were down- and up-regulated in WT and Enpp1ttw/ttw  
mice, respectively, fed a HPLD (Fig. 4b). Reduced body weight, shortened life span, reduced bone mass and 
ectopic calcification in kidney and aorta, all seen in Enpp1ttw/ttw mice fed a HPD, were all significantly rescued by 
vitamin D depletion, even under high phosphate loading (Fig. 4c–f). Inactivity and maranic phenotypes were 
prevented in Enpp1ttw/ttw mice by depletion of vitamin D from a HPD, suggesting that premature aging pheno-
types observed in Enpp1ttw/ttw mice under phosphate overload require high vitamin D signals, as is the case with 
kl/kl mice. Reduced Klotho expression in kidney seen following phosphate overload in Enpp1ttw/ttw mice was sig-
nificantly rescued by vitamin D depletion (Fig. 4g), suggesting feedback between Klotho and vitamin D signals. 
Furthermore, correlated with elevated renal Klotho expression, cyp27b1 expression was significantly downregu-
lated by vitamin D depletion under phosphate overload conditions in Enpp1ttw/ttw mice (Fig. 4g).
Fetuin A activity antagonizes ectopic calcification, and circulating Fetuin A levels are down-regulated with age48. 
Thus, we performed ELISA analysis to measure Fetuin A levels in WT or Enpp1ttw/ttw mice fed a HPD 
(Supplementary Fig. 9). Serum Fetuin A protein levels significantly decreased in response to a HPD in both 
genotypes and were equivalent in each (Supplementary Fig. 9). Although aging phenotypes such as short lifespan 
were rescued in response to a HPLD, low Fetuin A levels were not (Supplementary Fig. 9). Thus, aging phenotypes 
seen in Enpp1ttw/ttw mice fed a HPD are more likely associated with vitamin D rather than with Fetuin A signaling.
Next we crossed Enpp1ttw/ttw with VDR-deficient (VDR−/−) mice to yield Enpp1/VDR doubly-deficient (Enpp1ttw/
ttw/VDR−/−) mice (Fig. 5). VDR−/− mice die after weaning, but can survive beyond weaning if fed a high calcium 
diet49, 50. Thus, we fed Enpp1ttw/ttw/VDR−/− mice a high phosphate/high calcium diet starting at 8-weeks of age. 
Others have reported that calcium and phosphate overloading worsens OPLL phenotypes in Enpp1ttw/ttw mice39. 
However, ankylosis of the fore- and hindlimb seen in Enpp1ttw/ttw mice was efficiently rescued in Enpp1ttw/ttw/VDR−/−  
mice fed a high phosphate/high calcium diet (Fig. 5a). Reduced body weight, shortened life span, ectopic calci-
fication in kidney and aorta and ossification in ligaments seen in Enpp1ttw/ttw mice were all completely abrogated 
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Figure 3. Dietary phosphate overload decreases Klotho expression in kidney of Enpp1ttw/ttw mice. Eight-
week-old wild-type and Enpp1ttw/ttw mice were fed a ND or HPD for two weeks, and serum levels of FGF23 (a), 
1,25(OH)2D3 (b, left panel), 25(OH)D3 (b, right panel) or PTH (c) were analyzed. Klotho expression in kidney 
was analyzed by realtime PCR (d, left panel) and western blot (d, right panel). NaPi-IIa expression was also 
analyzed by western blot (d, right panel). Cyp27b1 expression in kidney was also analyzed by realtime PCR (e). 
Data in (a), (b) and (c) represent mean values of the indicated parameter ± S.D. (*p < 0.05; ***p < 0.001; ns, 
not significant; n = 6). Data in (d) and (e) represent mean Klotho or Cyp27b1 expression relative to β-actin ± SD 
(*p < 0.05; ***p < 0.001; ns, not significant; n = 6). Actin serves as an internal control (c). Representative data of 
at least three independent experiments are shown.
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in Enpp1ttw/ttw/VDR−/− mice even under phosphate overload and high calcium conditions (Fig. 5b–e). Moreover, 
Enpp1ttw/ttw/VDR−/− mice were active and not maranic compared with Enpp1ttw/ttw mice. In addition, Klotho 
expression in kidney was significantly high in Enpp1ttw/ttw/VDR−/− relative to Enpp1ttw/ttw mice under phosphate 
overload (Fig. 5f).
Discussion
How to achieve longevity is a fundamental concern for people living all over the world. The development of strate-
gies to promote healthy aging requires understanding molecular mechanisms underlying regulation of aging, and 
various molecules have been identified as aging-related51–55. Here, we show that under phosphate overload, Enpp1 
is required for renal Klotho expression, and its activity leads to down-regulation of 1,25(OH)2D3 production by 
inhibiting cyp27b1 expression and is part of a crucial axis that regulates phosphate and vitamin D metabolism 
(Fig. 6a). Enpp1 is also required to suppress FGF23 production by osteocytes, and Enpp1 loss elevates serum 
FGF23 levels owing to increased serum 1,25(OH)2D3 (Fig. 6b). Thus Enpp1 serves as an upstream mediator of the 
active Klotho/vitamin D3/FGF23 axis to suppress aging phenotypes (Fig. 6).
Previous studies demonstrate that Klotho plays a pivotal role in regulating aging2, stimulating a search for 
upstream regulators of Klotho56–58. Promoter methylation has been demonstrated to restrict Klotho expression in 
the kidney25. However, the targeting of potential upstream regulators of Klotho has not yet yielded animal models 
that resemble kl/kl mice in terms of premature aging. Here, we demonstrate that mutation of Enpp1 phenocopies 
kl/kl mice under conditions of phosphate overload. How Enpp1 regulates Klotho expression in kidney is unclear, 
and this remains to be addressed. However, since Enpp1 is reportedly expressed in osteocytes59, Enpp1 expressed 
in those cells may regulate renal Klotho expression. Further studies are needed to define the regulatory system 
between bone and kidney in the context of aging. It is also possible that Klotho expression is inhibited by phos-
phate overload itself. Indeed, in our study Klotho expression was down-regulated by phosphate overload even 
Figure 4. A low vitamin D diet antagonizes aging phenotypes seen in Enpp1ttw/ttw mice under phosphate 
overload. Eight-week-old wild-type and Enpp1ttw/ttw mice were fed a ND, HPD or a high phosphate/low vitamin 
D diet (HPLD) for eight weeks (a, b, e–h) or the indicated periods (c and d). The following parameters were 
then analyzed: serum levels of phosphorus, calcium and creatinine (a); 1,25(OH)2D3, FGF23 and PTH (b); body 
weight changes (each group; n = 10) (c); and survival rate (each group; n = 6) (d); bone mineral density (BMD) 
of femurs equally divided longitudinally by DEXA (e); ectopic calcification in kidney and aorta by von Kossa 
staining (f, left panel); and scoring of calcification area in aorta (f, right panel). Klotho expression in kidney 
was analysed by realtime PCR (g, left panel) and immnunohistological staining (g, right panel). (h) mRNA 
Cyp27b1 expression level in kidney was analyzed by realtime PCR. Data (a, b, e and f) represent mean values 
of the indicated parameter ± S.D. (#, p < 0.1; *p < 0.05; **p < 0.01; ***p < 0.001; ns, not significant; each n = 6, 
g Enpp1ttw/ttw mice fed a HPD vs HPLD). Data in (g) represent mean Klotho or Cyp27b1 expression relative to 
β-actin ± SD (*p < 0.05; n = 6). Representative data of at least two independent experiments are shown.
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in WT mice (Fig. 3d), although these changes were not statistically significant. Thus, low phosphate conditions 
caused by low vitamin D diet or VDR-deficiency likely inhibit Klotho down-regulation and contribute to reversal 
of aging phenotypes seen in Enpp1ttw/ttw mice fed a HPD. However, since Klotho expression was lower in Enpp1ttw/ttw  
than in WT mice, Enpp1 is likely required for Klotho expression. Nonetheless, VDR could be a therapeutic target 
to treat Enpp1-deficient patients.
Various Enpp1 gene mutations have been identified in humans, but phenotypes of patients harboring differ-
ing Enpp1 mutations vary from hypophosphatemia rickets or GACI to OPLL29, 30, 34. There are several types of 
hypophosphatemia rickets, among them XLH (Phex mutation), ARHR1 (DMP1 mutation) and ARHR2 (Enpp1 
mutation). Currently, patients with any of these conditions are treated with vitamin D3 (calcitriol) and phospho-
rus supplementation. The effects of such treatment on ARHR2 patients reportedly varies, and some patients are 
reportedly worsened by treatment60. Here we propose that supplementation of patients harboring an Enpp1 muta-
tion with vitamin D3 (calcitriol) and phosphorus is a potential contraindication, and that by contrast, inhibition 
of vitamin D signals should be considered.
Figure 5. Aging phenotypes seen in Enpp1ttw/ttw mice fed a high phosphate diet are abrogated by deletion of 
vitamin D receptor. Eight-week-old Enpp1ttw/ttw or Enpp1ttw/ttw/VDR−/− mice were fed a HPD for indicated 
periods (a and b) or eight weeks (c–e). The following parameters were then analyzed: gross appearance and 
forelimb shape (a); body weight changes (b); survival rate (each group; n = 5) (c); ectopic calcification in kidney 
and aorta by von Kossa staining (d, left panel); scoring of the calcification area in aorta (d, right panel); ectopic 
calcification around vertebral bones by micro-computed tomography (e); and Klotho expression in kidney 
by realtime PCR (f). Data (d) represent mean ectopic calcification area ± S.D. (**p < 0.01; n = 6). Data (e) 
represent mean Klotho expression relative to β-actin ± SD (*p < 0.05; n = 6). Representative data of at least two 
independent experiments are shown.
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Among Enpp1 mutations, GACI is associated with the most severe phenotypes, and patients exhibit calcifi-
cation of the aorta, with a mortality rate of approximately 85% by the age of 6 months18. GACI phenotypes are 
reminiscent of Enpp1ttw/ttw and Enpp1Δ/Δ mice fed a HPD or of kl/kl mice. To date, patients with GACI are treated 
with bisphosphonate61, 62. In animal models, Enpp1-Fc is reportedly effective in blocking HPD-induced death in 
Enpp1 mutant mice63. OPLL is a disease characterized by ossification of the PLL of the spine, although its molecu-
lar pathogenesis is unclear, and no therapeutic drugs have been established. Several gene mutations are reportedly 
associated with OPLL64, and Enpp1 mutations are detected in some OPLL patients34.
Recent advances in aging research have revealed that excess dietary phosphate intake accelerates aging and 
renal dysfunction65. Klotho plays an essential role in regulating phosphate levels, and kl/kl mice exhibit various 
aging phenotypes seen in humans44. The Enpp1-Klotho/FGF23-VDR axis is considered crucial to regulate human 
aging by controlling circulating phosphate levels. Moreover, Klotho and Fetuin A, the latter a soluble protein pro-
duced in the liver, are reportedly required to regulate circulating phosphate levels, and Fetuin A-deficient mice 
exhibit systemic ectopic calcification8. Fetuin A reportedly forms “calciprotein particles” to inhibit precipitation 
of calcium and phosphate to prevent unwanted calcification66, and circulating Fetuin A levels are reportedly 
down-regulated with age48. Thus, aging and changes in phosphate levels are regulated in a complex manner, and 
further studies are needed to clarify mechanisms underlying their relationship.
Overall, our study sheds light on the pathogenesis of Enpp1 mutation-related disease. We conclude that inhi-
bition of the vitamin D3-VDR pathway may be a better option to treat patients with Enpp1 mutations, although 
further clinical studies are required to test this strategy.
Methods
Mice and diets. The Enpp1ttw/ttw mouse is a spontaneous mutant harboring a nonsense mutation in Enpp1 
and first characterized in 1998 as an excellent model of ectopic ossification38, 67. We obtained Enpp1wt/ttw het-
erozygotes from the Central Institute for Experimental Animals (Kawasaki, Japan) and mated them to obtain 
Enpp1ttw/ttw homozygotes. Wild-type mice were obtained from Sankyo Lab Service (Tsuchiura, Ibaraki, Japan). 
Klotho-mutant (kl/kl)2, Klotho-overexpressing transgenic (Klotho Tg)68, and vitamin D receptor (VDR)-deficient 
(VDR−/−) mice were established previously69. Klotho Tg or VDR−/− mice were crossed with Enpp1ttw/ttw mice to 
yield Enpp1ttw/ttw/Klotho Tg or Enpp1ttw/ttwVDR−/− mice, respectively. Mice were fed either a normal phosphate 
diet (1% phosphate, ND), a HPD (1.5–2% phosphate, HPD), a high phosphate/low vitamin D (HPLD) diet or a 
high phosphate/high calcium diet starting at eight weeks of age for at least two weeks or indicated periods. An 
HPLD contains 0 units/100 g Vitamin D units. Other diets contain 240 units/100 g. Components of the HPD 
and HPLD are shown in the Supplementary Table 1. All animal methods were carried out in accordance with 
Figure 6. A schematic showing regulation of aging phenotypes under phosphate overload. (a) Normal 
Enpp1 maintains Klotho expression in kidney under dietary phosphate overload. Elevated serum phosphate 
levels promote FGF23 production from bone, and resultant FGF23 inhibits Cyp27 expression via a complex 
containing the FGF receptor (FGFR) and Klotho complex in kidney, inhibiting 1,25(OH)2D3 overproduction 
and suppressing aging phenotypes. (b) Enpp1 loss significantly downregulates renal Klotho expression under 
dietary phosphate overload. Elevated serum phosphate levels promote FGF23 production from bone, but 
the FGF23 signals are altered due to decreased Klotho expression. This outcome results elevates Cyp27b1 
expression, in turn leading to 1,25(OH)2D3 overproduction and inducing aging phenotypes.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7: 7786 | DOI:10.1038/s41598-017-07341-2
the Guidelines of the Keio University animal care committee. All experimental protocols were approved by that 
committee.
Quantitative PCR Analysis. Total RNAs were isolated from kidney by TRIzol reagent (Invitrogen Corp.), 
and cDNA synthesis was done using oligo(dT) primers and reverse transcriptase (Wako Pure Chemicals 
Industries). Quantitative PCR was performed using SYBR Premix ExTaq II reagent and a DICE Thermal cycler 
(Takara Bio Inc., Otsu, Shiga, Japan). Samples were matched to a standard curve generated by amplifying serially 
diluted products using the same PCR reactions. β-actin (Actb) expression served as an internal control. Primers 
for Klotho, Cyp27b1 and Actb were as follows.
Klotho-forward: 5′-GACAATGGCTTTCCTCCTTTACCT-3′
Klotho-reverse: 5′-TGCACATCCCACAGATAGACATTC-3′
Cyp27b1-forward: 5′-ACTCAGCTTCCTGGCTGAACTCTT-3′
Cyp27b1-reverse: 5′-GTAAACTGTGCGAAGTGTCCCAAA-3′
Runx2-forward: 5′-GACGTGCCCAGGCGTATTTC-3′
Runx2-reverse: 5′-AAGGTGGCTGGGTAGTGCATTC-3′
β-actin (Actb)-forward: 5′-TGAGAGGGAAATCGTGCGTGAC-3′
β-actin (Actb)-reverse: 5′-AAGAAGGAAGGCTGGAAAAGAG-3′
Western blotting. Harvested kidneys were homogenized in RIPA buffer (1% Tween 20, 0.1% SDS, 150 nM 
NaCl, 10 mM Tris-HCl (pH 7.4), 0.25 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, 10 g/ml leupep-
tin, 1 mM Na3VO4, 5 mM NaF (Sigma)). Lysates were collected by centrifugation at 15,000 rpm at 4 °C for 
10 min. Equivalent amounts of protein were separated by SDS/PAGE and transferred to a PVDF membrane 
(EMD Millipore Corporation). Proteins were detected using anti-Klotho (ab98111, abcam, Cambridge, UK), 
anti-NaPi-IIa (ab182099, abcam) and anti-Actin (A2066, Sigma) antibodies. Bands were visualized using ECL 
Western Blotting Detection Reagent (GE Healthcare, Uppsala, Sweden).
Analysis of skeletal morphology. Bone mineral density (BMD) of whole femurs was measured 
by Dual-energy X-ray absorptiometry (DEXA) using a DCS-600R system (Aloka Co. Ltd., Tokyo, Japan). 
Vertebral bones and surrounding tissues including intervertebral discs and the posterior longitudinal ligament 
were scanned by a micro-computed tomography (R_mCT2; Rigaku Corp., Tokyo, Japan) at 90 kV and 160 A. 
Two-dimensional regions of interest were created at the level of the cervical spine and Achilles tendon using 
TRI/3D-BON software (RATOC Co. Ltd., Tokyo, Japan).
Histopathological analysis. Kidney, aorta and skin from euthanized mice were fixed in 10% 
phosphate-buffered formalin, and embedded in paraffin. Tissues were sectioned and stained with hematoxylin 
and eosin (H&E) and using von Kossa methods. Slides were examined by light microscopy (BIOREVO, BZ-9000 
(Keyence, Osaka, Japan)) for tissue mineralization. Relative calcification areas in kidney and aorta were calculated 
using microscopic image analysis software BZ-II analyzer (Keyence). Kidney sections were also stained using 
anti-p16 INK4A (10883-1-AP, Proteintech, Rosemont, IN, USA) or anti-Klotho (ab98111, abcam) followed by 
Alexa488-conjugated goat anti-rabbit IgG H&L (Alexa Fluor® (ab150077, abcam), and nuclei were stained with 
DAPI (Wako Pure Chemicals Industries, Osaka, Japan). Senescence-associated beta-galactosidase was stained 
using a SA-β-gal kit (#9860, Cell Signaling, Danvers, MA). Then, sections were observed under a fluorescence 
microscope (Keyence, Osaka, Japan).
ELISA. Serum levels of FGF23 (full length, KAINOS Lab Inc., Tokyo, Japan), RANKL (R&D, systems, Inc., 
Minneapolis, MN), OPG (R&D) CTx (Immunodiagnostic Systems Limited, Boldon, UK), urinary Fetuin A 
(R&D) and α-Klotho (Immuno-Biological Laboratories Co, Ltd, Gunma, Japan) were measured by using an 
ELISA kit based on the manufacturers’ instructions.
Biochemical analyses. Peripheral blood was obtained from the postorbital vein. Serum was isolated by cen-
trifugation at 6,000 rpm for 15 minutes at 4 °C and stored at −80 °C. 1,25(OH)2D3 and 25(OH)D3 levels in sera 
were measured using a 25OH-Vitamin D total-RIA-CT kit (DIAsource, Ottignies-Louvain-la-Neuve, Belgium) 
and an ECLIA kit (Cobas, Roche Diagnostics, Basel, Switzerland), respectively.
Statistical analysis. Data were analyzed using a two-tailed Student’s t-test. For all graphs, data are rep-
resented as means ± standard deviation (SD). A p-value less than 0.05 was considered statistically significant 
(*p < 0.05; **p < 0.01; ***p < 0.001).
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